Newsbenzinga
Sanofi's Sarclisa Becomes First EU-Approved Anticancer Therapy Via On-Body Injector, Covering All Four Existing Multiple Myeloma Indications
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…